Mahesh Karande
2022
In 2022, Mahesh Karande earned a total compensation of $3.8M as President and Chief Executive Officer at Omega Therapeutics, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $246,400 |
|---|---|
| Option Awards | $3,007,300 |
| Salary | $555,833 |
| Other | $10,650 |
| Total | $3,820,183 |
Karande received $3M in option awards, accounting for 79% of the total pay in 2022.
Karande also received $246.4K in non-equity incentive plan, $555.8K in salary and $10.7K in other compensation.
Rankings
In 2022, Mahesh Karande's compensation ranked 915th out of 5,625 executives tracked by ExecPay. In other words, Karande earned more than 83.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 915 out of 5,625 | 84th |
Division Manufacturing | 417 out of 3,053 | 86th |
Major group Chemicals And Allied Products | 147 out of 1,380 | 89th |
Industry group Drugs | 133 out of 1,281 | 90th |
Industry Biological Products, Except Diagnostic Substances | 31 out of 295 | 90th |
Source: SEC filing on April 29, 2024.
Karande's colleagues
We found one more compensation record of an executive who worked with Mahesh Karande at Omega Therapeutics in 2022.
2022
Yan Moore
Omega Therapeutics